36 Chapter 2 19. Braakhekke M, Kamphuis EI, Dancet EA, Mol F, van der Veen F, Mol BW. Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper. Fertil Steril. 2014;101(5):1203-4. 20. van Welie N, Dreyer K, van Rijswijk J, Verhoeve HR, Goddijn M, Nap AW, et al. Treatment effect of oil-based contrast is related to experienced pain at HSG: a post-hoc analysis of the randomised H2Oil study. Hum Reprod. 2019;34(12):2391-8. 21. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8(2):141-54. 22. van Eekelen R, Scholten I, Tjon-Kon-Fat RI, van der Steeg JW, Steures P, Hompes P, et al. Natural conception: repeated predictions over time. Hum Reprod. 2017;32(2):346-53. 23. Watson A, Vandekerckhove P, Lilford R, Vail A, Brosens I, Hughes E. A meta-analysis of the therapeutic role of oil soluble contrast media at hysterosalpingography: a surprising result? Fertility and Sterility. 1994;61(3):470-7. 24. van Rijswijk J, van Welie N, Dreyer K, Tajik P, Lambalk CB, Hompes P, et al. Tubal flushing with oil- or water-based contrast medium: can we identify markers that indicate treatment benefit? Hum Reprod Open. 2019;2019(3):hoz015.
RkJQdWJsaXNoZXIy MTk4NDMw